Literature DB >> 25436311

Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.

Takashi Kobayashi, Masayo Kawakamil, Yoshiaki Hara, Sadaaki Shioiri, Masamichi Yasuno, Masanori Teruya, Michio Kaminishi.   

Abstract

BACKGROUND/AIMS: Little is known about the ability of the inflammation-based Glasgow prognostic score (GPS).
METHODOLOGY: 106 patients who underwent curative resection for colorectal liver metastasis (CRLM) were analyzed. Patients with an elevated Creactive protein concentration (>10 mg/L) and hypoalbuminemia (<35 g/L) at admission were assigned a GPS 2, those with only 1 of these biochemical abnormalities were assigned a GPS 1, and those without either abnormality were assigned a GPS 0.
RESULTS: Multivariate analysis showed that 2 variables, carcinoembryonic antigen (CEA) concentration > 30 ng/mL and a GPS 1 or 2, were independently prognostic of survival. Patients were classified into 3 groups on the basis of these 2 variables. Patients with GPS 1 or 2 and CEA concentration > 30 ng/mL were assigned a new score of 2, those with either 1 factor were assigned a new score of 1, and those with neither factors were assigned a new score of 0. The 5-year overall survival rates of new scores of 0, 1, 2 were 71.5%, 31.6%, and 0%, respectively (P < 0.0001).
CONCLUSIONS: This simple staging system may be able to identify a subgroup of patients who are eligible for curative resection but show poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25436311

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.

Authors:  Rafif E Mattar; Faisal Al-Alem; Eve Simoneau; Mazen Hassanain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies.

Authors:  Yangyang Liu; Xingkang He; Jie Pan; Shujie Chen; Liangjing Wang
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

3.  An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.

Authors:  Feifei Sun; Jia Zhu; Suying Lu; Zijun Zhen; Juan Wang; Junting Huang; Zonghui Ding; Musheng Zeng; Xiaofei Sun
Journal:  BMC Cancer       Date:  2018-01-02       Impact factor: 4.430

4.  Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era.

Authors:  Siwei Liu; Jie Shi; Honggang Guo; Fangfang Xu; Min Wei; Kai Sun; Yuqing Chen
Journal:  Cancer Manag Res       Date:  2019-11-05       Impact factor: 3.989

5.  Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.

Authors:  Fu Ming-Sheng; Du Mei-Ling; Cai Xun-Quan; Hu Yuan-Xin; Zhang Wei-Jie; Pan Qin-Cong
Journal:  Can J Gastroenterol Hepatol       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.